Scientific, Regulatory & Quality
Regulatory Strategy
Navigate the regulatory path with clarity and confidence.
A well-built and well-executed regulatory strategy is essential to development and approval. In fact, it could mean the difference between market success and costly delays.
Early- and mid-stage life science companies often treat regulatory strategy as a milestone to address later in development. In reality, it serves as the core roadmap and operating system that aligns nonclinical development and clinical development, CMC activities, commercialization planning, and funding strategy.
Syner-G streamlines your path to market through structured, end-to-end regulatory strategy and global submission support. We design and execute strategies that reduce risk, avoid delays, and prepare your team for every interaction with health authorities, while equipping stakeholders with a clear and unified plan.
Our approach delivers living, decision-driven tools that keep internal teams, investors, CROs, and regulators aligned. The result is greater clarity, stronger execution, and accelerated progress toward key milestones and ultimately the delivery of breakthrough therapies to patients.
Challenges we can help solve:
Regulatory uncertainty and evolving expectations
We help you interpret and apply global regulatory requirements through a fit-for-purpose, risk-based approach grounded in scientific and operational insight. Whether you’re pursuing an IND, NDA, BLA, or global filings, our experts guide you through every step with clarity and precision.
Misalignment between clinical, CMC, and regulatory strategy
We align clinical development, CMC, and regulatory strategy into a single, cohesive plan so teams are not operating in silos. This ensures decisions are coordinated, sequencing is optimized, and costly rework or delays are avoided as programs progress.
Complex, time-sensitive submission demands
Our experienced scientists craft clear, compliant regulatory documents that meet global standards and support every step of the submission process. From authoring and editing to formatting, QC, and coordination, we help clients meet tight timelines for INDs, NDAs, MAAs, and agency briefings—without compromising quality.
Increased complexity in global lifecycle management
We provide strategic and operational support for global variations, line extensions, and post-approval changes—helping clients maintain product quality, meet evolving regulatory expectations, and keep therapies accessible to patients worldwide.
Growing volume and complexity of regulatory submissions
Our teams support authoring, QC, formatting, and coordination for large-scale regulatory submissions, from routine updates to major global filings—ensuring consistency, efficiency, and regulatory compliance across functions and geographies.
Unclear development pathways, milestones, and decision points
We bring structure and clarity to your development path by defining key milestones, decision points, and data requirements. This creates a transparent, actionable roadmap that supports confident decision-making and keeps stakeholders aligned at every stage.
Client Return Rate
Assets Supported
INDs Filed
NDAs / BLAs Filed
Ensure a smooth journey from concept through commercialization.
Our Approach
Seamless regulatory support — across phases, functions, and geographies.
Our team understands the complexities of development from both a scientific and regulatory perspective. This approach ensures that your non-clinical and clinical strategies are expertly developed with a clear understanding of international requirements.
- Regulatory: aligned with FDA, EMA, and global regulations
- Audits & Assessments: gap assessments, risk registers, and risk mitigation
- Roadmaps & Custom Support: to speed up timelines—by months or even years
We can help with:
Global Regulatory Strategy – North America, EU, APAC, LATAM, RoW
Regulatory Roadmap
Nonclinical & Clinical Strategy Alignment
Quarterly Roadmap Refresh & Governance
Target Product Profile (TPP) Development
Clinical Feasibility Assessments
Clinical Development Plan (CDP)
Gap Analyses
A complete, fully-integrated solution.
Discovery Sciences
CMC Strategy & Development
Medical Writing
Quality & Compliance
Related Resources
All Resources
Let's move from science to success.
Let’s Talk